F. Boulahbal

发表

Rifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugs.

R. Lumb, A. Van Deun, E. Kurbatova, 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Mycobacterium tuberculosis genotype Beijing: About 15 strains and their part in MDR-TB outbreaks in Algeria.

D. Yala, F. Boulahbal, M. Ifticene, 2012, International journal of mycobacteriology.

Molecular characterization of Mycobacterium bovis strains isolated from cattle slaughtered at two abattoirs in Algeria

N. Smith, J. Zinsstag, N. Sahraoui, 2009, BMC veterinary research.

Mycobacterial Growth Indicator Tube Versus the Proportion Method on Löwenstein-Jensen Medium for Antibiotic Susceptibility Testing of Mycobacterium tuberculosis

V. Jarlier, C. Truffot-Pernot, J. Grosset, 2000, European Journal of Clinical Microbiology and Infectious Diseases.

Prevalence of primary and acquired resistance of Mycobacterium tuberculosis to antituberculosis drugs in Benin after 12 years of short-course chemotherapy.

A. Trébucq, S. Anagonou, M. Gninafon, 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

A national survey of human Mycobacterium bovis infection in France. Network of Microbiology Laboratories in France.

V. Jarlier, J. Robert, C. Truffot-Pernot, 1999, The International Journal of Tuberculosis and Lung Disease.

Use of two methods of analysis to estimate the annual rate of tuberculosis infection in Southern Algeria.

R. Liard, S. Perdrizet, M. Tazir, 1996, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[A therapeutic trial of a combination of 3 essential drugs in a short course of chemotherapy in tuberculosis. Results 6 months after the end of treatment].

P. Chaulet, F. Boulahbal, M. Chiheb, 1990, Revue des maladies respiratoires.

TREATMENT OF FAILURE AND RELAPSE CASE OF PULMONARY TUBERCULOSIS WITHIN A NATIONAL PROGRAME BASED ON SHORT-COURSE CHEMOTHERAPY

N. Zidouni, P. Chaulet, F. Boulahbal, 1992 .

[Controlled study comparing 3 daily chemotherapy regimens for six months in pulmonary tuberculosis in routine practice in Algiers. Results at 30 months].

P. Chaulet, M. Tazir, F. Boulahbal, 1985, Revue des maladies respiratoires.

The interest of follow-up of resistance of the tubercle bacillus in the evaluation of a programme.

M. Tazir, F. Boulahbal, S. Khaled, 1989, Bulletin of the International Union against Tuberculosis and Lung Disease.

Evaluation of the chloride and bromide salts of cetylpyridium for the transportation of sputum in tuberculosis bacteriology.

H. David, M. Tazir, F. Boulahbal, 1979, Tubercle.

The difficulties of childhood tuberculosis diagnosis

F. Boulahbal, M. Ifticene, Amal Djouahra, 2016, International journal of mycobacteriology.

Surveillance of drug resistance for tuberculosis control: why and how?

J. Grosset, P. Chaulet, F. Boulahbal, 1995, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Is second-line anti-tuberculosis drug susceptibility testing reliable?

G. Bai, K. Kam, L. Rigouts, 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Genetic Diversity of Mycobacterium africanum Clinical Isolates Based on IS6110-Restriction Fragment Length Polymorphism Analysis, Spoligotyping, and Variable Number of Tandem DNA Repeats

N Rastogi, C Sola, Nalin Rastogi, 2001, Journal of Clinical Microbiology.